A REVIEW ON FORMULATION AND EVALUATION TRANSDERMAL PATCHES FOR CHRONIC PAIN RELIFE
Chronic pain is a persistent and multifactorial condition that can impair mobility, sleep, mood, and quality of life. Transdermal and topical patch systems offer an alternative or adjunct to conventional oral and parenteral dosage forms by delivering analgesic agents through or into the skin. Their potential benefits include convenient administration, controlled delivery, reduced dosing frequency, avoidance of gastrointestinal exposure, and—depending on the product—local or systemic action. This narrative review describes skin-barrier physiology, patch architecture, formulation materials, candidate analgesics, manufacturing approaches, evaluation methods, quality attributes, safety considerations, and emerging technologies. Particular attention is given to distinguishing locally acting topical analgesic patches from systemic transdermal products. Critical tests include drug content and uniformity, in-vitro release, skin permeation, adhesion, mechanical properties, irritation/sensitization, and stability. The review also discusses limitations such as the stratum corneum barrier, variability in skin condition, adhesion failure, dose constraints, and risks associated with potent drugs. Microneedles, iontophoresis, and other enhancement strategies may broaden the range of molecules delivered, but require rigorous safety and translation studies. The review concludes that successful patch development depends on matching the drug, target pain mechanism, delivery objective, polymer–adhesive system, and quality strategy.
Authors
- Jay Thorat
- Bhavana Tonde
- Snehal Fand
- Shital Thorat
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-14
- DOI
- https://doi.org/10.5281/zenodo.24218311
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00